Short Interest in Agape ATP Corporation (NASDAQ:ATPC) Expands By 5,924.2%

Agape ATP Corporation (NASDAQ:ATPC) saw a large increase in short interest in the month of May. As of May 29th, there was short interest totaling 314,161 shares, an increase of 5,924.2% from the May 14th total of 5,215 shares. Based on an average trading volume of 12,517,087 shares, the days-to-cover ratio is presently 0.0 days. Approximately 32.0% of the shares of the company are short sold.

Institutional Trading of Agape ATP

An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC lifted its holdings in Agape ATP Corporation (NASDAQ:ATPC) by 95.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the period. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent filing with the Securities & Exchange Commission. 0.01% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on ATPC. Wall Street Zen upgraded Agape ATP from a “sell” rating to a “hold” rating in a research note on Sunday, April 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agape ATP in a research report on Friday, May 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Agape ATP currently has an average rating of “Sell”.

Agape ATP Stock Performance

NASDAQ ATPC traded up $0.07 on Tuesday, reaching $3.12. 1,513,020 shares of the company’s stock traded hands, compared to its average volume of 2,429,269. The firm has a market cap of $3.12 million, a price-to-earnings ratio of -2.35 and a beta of 0.05. The stock has a 50 day moving average price of $2.82 and a 200-day moving average price of $9.83. Agape ATP has a fifty-two week low of $1.72 and a fifty-two week high of $85.50.

Agape ATP (NASDAQ:ATPC) last posted its earnings results on Friday, May 15th. The company reported ($0.33) earnings per share (EPS) for the quarter. Agape ATP had a negative net margin of 125.89% and a negative return on equity of 8.43%. The business had revenue of $0.27 million for the quarter.

About Agape ATP

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.